Related Articles
JDP1 (DNAJC12/Hsp40) expression in breast cancer and its association with estrogen receptor status
Androgen receptor decreases CMYC and KRAS expression by upregulating let-7a expression in ER-, PR-, AR+ breast cancer
Evaluation of melatonin treatment in primary culture of canine mammary tumors
Predictive value of estrogen receptor status as assessed by ligand-binding assay in patients with early-stage breast cancer treated with breast conserving surgery and radiation therapy
Microarray phosphatome profiling of breast cancer patients unveils a complex phosphatase regulatory role of the MAPK and PI3K pathways in estrogen receptor-negative breast cancers